These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

313 related items for PubMed ID: 19467459

  • 1. [Quantitative dynamic MRI and localisation of non-palpable prostate cancer].
    Cornud F, Beuvon F, Thévenin F, Chauveinc L, Vieillefond A, Descazeaux A, Flam T.
    Prog Urol; 2009 Jun; 19(6):401-13. PubMed ID: 19467459
    [Abstract] [Full Text] [Related]

  • 2. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
    Yoshizako T, Wada A, Hayashi T, Uchida K, Sumura M, Uchida N, Kitagaki H, Igawa M.
    Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
    [Abstract] [Full Text] [Related]

  • 3. Dynamic contrast-enhanced magnetic resonance imaging for localization of recurrent prostate cancer after external beam radiotherapy.
    Haider MA, Chung P, Sweet J, Toi A, Jhaveri K, Ménard C, Warde P, Trachtenberg J, Lockwood G, Milosevic M.
    Int J Radiat Oncol Biol Phys; 2008 Feb 01; 70(2):425-30. PubMed ID: 17881141
    [Abstract] [Full Text] [Related]

  • 4. Description of magnetic resonance imaging-derived enhancement variables in pathologically confirmed prostate cancer and normal peripheral zone regions.
    Zelhof B, Lowry M, Rodrigues G, Kraus S, Turnbull L.
    BJU Int; 2009 Sep 01; 104(5):621-7. PubMed ID: 19281464
    [Abstract] [Full Text] [Related]

  • 5. Prostate cancer detection with multi-parametric MRI: logistic regression analysis of quantitative T2, diffusion-weighted imaging, and dynamic contrast-enhanced MRI.
    Langer DL, van der Kwast TH, Evans AJ, Trachtenberg J, Wilson BC, Haider MA.
    J Magn Reson Imaging; 2009 Aug 01; 30(2):327-34. PubMed ID: 19629981
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Evaluation of normal prostate tissue, chronic prostatitis, and prostate cancer by quantitative perfusion analysis using a dynamic contrast-enhanced inversion-prepared dual-contrast gradient echo sequence.
    Franiel T, Lüdemann L, Rudolph B, Rehbein H, Staack A, Taupitz M, Prochnow D, Beyersdorff D.
    Invest Radiol; 2008 Jul 01; 43(7):481-7. PubMed ID: 18580330
    [Abstract] [Full Text] [Related]

  • 8. Analysis of prostate DCE-MRI: comparison of fast exchange limit and fast exchange regimen pharmacokinetic models in the discrimination of malignant from normal tissue.
    Lowry M, Zelhof B, Liney GP, Gibbs P, Pickles MD, Turnbull LW.
    Invest Radiol; 2009 Sep 01; 44(9):577-84. PubMed ID: 19668002
    [Abstract] [Full Text] [Related]

  • 9. Combined quantitative dynamic contrast-enhanced MR imaging and (1)H MR spectroscopic imaging of human prostate cancer.
    van Dorsten FA, van der Graaf M, Engelbrecht MR, van Leenders GJ, Verhofstad A, Rijpkema M, de la Rosette JJ, Barentsz JO, Heerschap A.
    J Magn Reson Imaging; 2004 Aug 01; 20(2):279-87. PubMed ID: 15269954
    [Abstract] [Full Text] [Related]

  • 10. Prostate cancer screening: the clinical value of diffusion-weighted imaging and dynamic MR imaging in combination with T2-weighted imaging.
    Tanimoto A, Nakashima J, Kohno H, Shinmoto H, Kuribayashi S.
    J Magn Reson Imaging; 2007 Jan 01; 25(1):146-52. PubMed ID: 17139633
    [Abstract] [Full Text] [Related]

  • 11. Detection of prostate cancer in peripheral zone: comparison of MR diffusion tensor imaging, quantitative dynamic contrast-enhanced MRI, and the two techniques combined at 3.0 T.
    Li C, Chen M, Li S, Zhao X, Zhang C, Luo X, Zhou C.
    Acta Radiol; 2014 Mar 01; 55(2):239-47. PubMed ID: 23892233
    [Abstract] [Full Text] [Related]

  • 12. Dynamic contrast-enhanced-magnetic resonance imaging evaluation of intraprostatic prostate cancer: correlation with radical prostatectomy specimens.
    Puech P, Potiron E, Lemaitre L, Leroy X, Haber GP, Crouzet S, Kamoi K, Villers A.
    Urology; 2009 Nov 01; 74(5):1094-9. PubMed ID: 19773038
    [Abstract] [Full Text] [Related]

  • 13. Diffusion-weighted and dynamic contrast-enhanced MRI of prostate cancer: correlation of quantitative MR parameters with Gleason score and tumor angiogenesis.
    Oto A, Yang C, Kayhan A, Tretiakova M, Antic T, Schmid-Tannwald C, Eggener S, Karczmar GS, Stadler WM.
    AJR Am J Roentgenol; 2011 Dec 01; 197(6):1382-90. PubMed ID: 22109293
    [Abstract] [Full Text] [Related]

  • 14. Combined diffusion-weighted and dynamic contrast-enhanced MRI for prostate cancer diagnosis--correlation with biopsy and histopathology.
    Kozlowski P, Chang SD, Jones EC, Berean KW, Chen H, Goldenberg SL.
    J Magn Reson Imaging; 2006 Jul 01; 24(1):108-13. PubMed ID: 16767709
    [Abstract] [Full Text] [Related]

  • 15. Differentiation of prostate cancer from normal prostate tissue in an animal model: conventional MRI and dynamic contrast-enhanced MRI.
    Gemeinhardt O, Lüdemann L, Prochnow D, Abramjuk C, Taupitz M, Hamm B, Beyersdorff D.
    Rofo; 2005 Jul 01; 177(7):935-9. PubMed ID: 15973594
    [Abstract] [Full Text] [Related]

  • 16. Wash-in rate on the basis of dynamic contrast-enhanced MRI: usefulness for prostate cancer detection and localization.
    Kim JK, Hong SS, Choi YJ, Park SH, Ahn H, Kim CS, Cho KS.
    J Magn Reson Imaging; 2005 Nov 01; 22(5):639-46. PubMed ID: 16200542
    [Abstract] [Full Text] [Related]

  • 17. Multiparametric MRI is helpful to predict tumor focality, stage, and size in patients diagnosed with unilateral low-risk prostate cancer.
    Delongchamps NB, Beuvon F, Eiss D, Flam T, Muradyan N, Zerbib M, Peyromaure M, Cornud F.
    Prostate Cancer Prostatic Dis; 2011 Sep 01; 14(3):232-7. PubMed ID: 21423266
    [Abstract] [Full Text] [Related]

  • 18. Dynamic contrast enhanced, pelvic phased array magnetic resonance imaging of localized prostate cancer for predicting tumor volume: correlation with radical prostatectomy findings.
    Villers A, Puech P, Mouton D, Leroy X, Ballereau C, Lemaitre L.
    J Urol; 2006 Dec 01; 176(6 Pt 1):2432-7. PubMed ID: 17085122
    [Abstract] [Full Text] [Related]

  • 19. Principal component analysis of dynamic contrast enhanced MRI in human prostate cancer.
    Eyal E, Bloch BN, Rofsky NM, Furman-Haran E, Genega EM, Lenkinski RE, Degani H.
    Invest Radiol; 2010 Apr 01; 45(4):174-81. PubMed ID: 20177391
    [Abstract] [Full Text] [Related]

  • 20. Prostate cancer detection on dynamic contrast-enhanced MRI: computer-aided diagnosis versus single perfusion parameter maps.
    Sung YS, Kwon HJ, Park BW, Cho G, Lee CK, Cho KS, Kim JK.
    AJR Am J Roentgenol; 2011 Nov 01; 197(5):1122-9. PubMed ID: 22021504
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.